Ownership and insider activity for ClearPoint Neuro, Inc. (CLPT): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
ClearPoint Neuro, Inc. is a medical technology firm primarily operating within the United States. The company specializes in developing and commercializing sophisticated systems that facilitate minimally invasive brain surgeries, guided by real-time magnetic resonance imaging (MRI) during the procedure.
Price
| Price | $13.40 |
| Market Cap | $402M |
| Exchange | NASDAQ |
| Country | US |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-09-02 | BURNETT JOSEPH | M-Exempt | 12,517 | $43K |
| 2026-09-02 | BURNETT JOSEPH | M-Exempt | 12,517 | $43K |
| 2026-07-01 | FLETCHER R JOHN | A-Award | 662 | $12K |
| 2026-07-01 | Richards Timothy T. | A-Award | 222 | $4K |
| 2026-06-30 | STIGALL L. JEREMY | A-Award | 1,781 | $21K |
| 2026-06-30 | D'Alessandro Danilo | A-Award | 1,085 | $13K |
| 2026-06-30 | BURNETT JOSEPH | A-Award | 1,361 | $16K |
| 2026-06-29 | BURNETT JOSEPH | M-Exempt | 20,000 | $50K |
| 2026-06-29 | BURNETT JOSEPH | M-Exempt | 20,000 | $50K |
| 2026-06-29 | BURNETT JOSEPH | S-Sale | 20,000 | $388K |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.3M | $9.3M | $3.1M | $5.7M | $20.1M | $54.1M | $27.6M | $23.1M | $20.1M | $45.9M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 | 0 | $9.9M | 0 | 0 | 0 |
| Receivables | $865943 | $949415 | $1.2M | $1.1M | $1.9M | $2.3M | $2.7M | $3.9M | $4.7M | $7.3M |
| Inventory | $1.8M | $2.3M | $2.1M | $3.2M | $3.2M | $4.9M | $9.3M | $7.9M | $6.9M | $8.4M |
| Total Current Assets | $6.1M | $12.7M | $6.7M | $10.4M | $25.5M | $61.9M | $51.2M | $36.2M | $33.4M | $63.6M |
| Property, Plant & Equipment | $328249 | $267667 | $377706 | $821000 | $3.1M | $2.8M | $2.7M | $5.0M | $5.1M | $11.1M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $7.5M |
| Intangible Assets | 0 | 0 | 0 | 0 | $353000 | $265000 | $1.0M | $1.0M | $484000 | $13.9M |
| Total Assets | $7.4M | $13.9M | $7.9M | $11.9M | $29.5M | $65.6M | $55.5M | $42.7M | $39.2M | $97.7M |
| Accounts Payable | $1.5M | $759445 | $500928 | $966000 | $300000 | $427000 | $272000 | $393000 | $1.3M | $1.3M |
| Short-term Debt | 0 | $2.0M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Liabilities | $3.0M | $4.4M | $2.0M | $3.8M | $3.2M | $4.8M | $6.8M | $7.4M | $10.4M | $10.8M |
| Long-term Debt | $4.5M | $2.9M | $3.5M | $2.1M | $21.3M | $9.8M | $9.9M | $9.9M | 0 | $49.1M |
| Total Liabilities | $8.2M | $8.1M | $6.3M | $7.3M | $27.1M | $16.8M | $18.6M | $21.5M | $13.8M | $69.7M |
| Retained Earnings | -$93.9M | -$101.0M | -$107.2M | -$112.7M | -$119.5M | -$133.9M | -$150.4M | -$172.5M | -$191.4M | -$216.9M |
| Total Equity | -$756069 | $5.8M | $1.5M | $4.6M | $2.4M | $48.8M | $36.9M | $21.2M | $25.4M | $28.0M |
| Total Debt | $4.5M | $4.9M | $3.5M | $2.5M | $24.1M | $12.3M | $12.0M | $13.9M | $3.6M | $58.2M |
| Net Debt | $1.2M | -$4.4M | $379508 | -$3.2M | $4.0M | -$41.8M | -$25.5M | -$9.2M | -$16.5M | $12.3M |
| Working Capital | $3.1M | $8.3M | $4.6M | $6.6M | $22.3M | $57.1M | $44.4M | $28.7M | $23.0M | $52.8M |
Financial Health
| Debt / Equity | 5.93 |
| Current Ratio | 4.73 |
Profitability
| Return on Equity | -188.09% |
| Return on Invested Capital | -40.49% |
| Return on Assets | -39.85% |
| Gross Margin | 62.61% |
| Operating Margin | -73.42% |
| Net Margin | -81.76% |
Related companies: AKBA · AVNS · CMPS · CTKB · LAB · OFIX · SIBN
Explore sector: Healthcare · Medical - Devices
More sections of CLPT: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks